概括
禽肉瘤病毒 (ASV) 蛋白质pp60src通过酸化34,000达尔顿蛋白质来转化细胞. 这种细胞蛋白在体外和在ASV转化细胞中是pp60src激酶活性的直接基质.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 鸟类肉瘤病毒 (ASV) 编码了pp60src,这是一个涉及细胞转化的蛋白质激酶.
- 鉴定pp60src的细胞基质对于理解病毒瘤发生至关重要.
研究的目的:
- 为了识别和表征由pp60src.src.pp60所酸化的细胞蛋白质.
- 确定 pp60src 是否在特定转化环境中直接化已识别的基质.
主要方法:
- 西方涂抹检测蛋白质酸化.
- 在体外激酶测试使用纯化的pp60src和细胞蛋白.
- 片映射用于识别酸化部位.
主要成果:
- 一个34,000-达尔顿 (34K) 的细胞蛋白被确定为pp60src基质.
- 34K蛋白的酸化在感染ASV的鸟类和哺乳动物细胞中是转化特异性的.
- 在体外测试证实34K是pp60src激酶活性的直接基质.
- 酸化发生在体内和体外相同的部位.
结论:
- 34K蛋白是pp60src激酶活性的直接细胞点.
- pp6034K蛋白质的src介导酸化有助于病毒转化.
- 这一发现阐明了ASV诱导的瘤发生的关键分子机制.
相关概念视频
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...


